Canntab Therapeutics
Laxminarayan Joshi currently serves as the Chief Scientific Officer at Canntab Therapeutics Ltd. since May 2020. In addition, Laxminarayan has held the position of President at Pharmagenerics Solutions Inc. since March 2014 and has been the Director of Research and Development at Cmax Technologies Inc. since March 2009. Prior experience includes serving as the Director of R&D at Orbus Pharma Inc. from 2004 to 2009. Laxminarayan's educational background includes studies at Uttar Pradesh Jobs.
This person is not in the org chart
This person is not in any teams
Canntab Therapeutics
1 followers
Canntab Therapeutics ahs developed a product line of solid oral dose delivery systems including extended release (XR), flash melt, immediate release, modified release and bi-layered tablet solutions that provide a variety of cannabinoid and terpenoid blends in exacting dosages.